Broadcom Inc. (NASDAQ:AVGO) shares are trading lower Friday, reversing after rising following a strong fourth quarter earnings report on Thursday after the market closed. What To Know: Broadcom reported adjusted earnings per share of $1.95, beating the consensus estimate of…
The Dow hit a fresh record high on Friday morning as investors continued to turn away from tech stocks for the relative safety of industrials and financial stocks. UNH stock is climbing. See the chart and price action here. The…
Jiuzi Holdings (NASDAQ:JZXN) has secured institutional commitments that could boost its private placement financing to $1 billion, marking a major step as the company rapidly pivots to crypto asset services. The new commitments greatly expand the private placement first announced…
ProPetro Holding Corp. (NYSE:PUMP) has secured a new power services contract in the Permian Basin, expanding its PROPWR business as demand for on-site energy solutions rises across West Texas and New Mexico. PROPWR will provide turnkey power systems and distributed…
The U.S. Food and Drug Administration (FDA) on Thursday approved Amgen Inc.’s (NASDAQ:AMGN) Uplinza (inebilizumab-cdon) for generalized myasthenia gravis (gMG). The approval covers adult patients who are anti-acetylcholine receptor (AChR) and anti-muscle-specific tyrosine kinase (MuSK) antibody positive. gMG is a…
Tilray Brands, Inc. (NASDAQ:TLRY) shares are trading higher Friday following a report suggesting that President Donald Trump is expected to reclassify marijuana as a Schedule III drug. Tilray Brands stock is charging ahead with explosive momentum. What’s fueling TLRY momentum?…
Taiwan ramped up its artificial intelligence ambitions on Friday as President Lai Ching-te inaugurated a new cloud computing center built around one of the island’s most powerful supercomputers. Lai Ching-te on Friday opened a new cloud computing center equipped with…
Cannabis stocks haven't moved like this in years, and it took a rare one-two punch to jolt the sector back to life: a Washington Post scoop hinting that President Donald Trump wants to reclassify marijuana into Schedule III — and…
On Thursday, the U.S. Food and Drug Administration (FDA) approved GSK Plc’s (NYSE:GSK) supplemental New Drug Application for gepotidacin as an oral option for uncomplicated urogenital gonorrhoea. GSK stock is showing upward bias. What’s the outlook for GSK shares? Gonorrhoea is…
Broadcom Inc (NASDAQ:AVGO) just pulled off the most lucrative "quiet pivot" in Silicon Valley — and the market almost missed it while obsessing over a routine 5% dip. Track AVGO stock here. The company that spent half a century being…